You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

Details for New Drug Application (NDA): 206966


✉ Email this page to a colleague

« Back to Dashboard


NDA 206966 describes XEGLYZE, which is a drug marketed by Hatchtech and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the XEGLYZE profile page.

The generic ingredient in XEGLYZE is abametapir. One supplier is listed for this compound. Additional details are available on the abametapir profile page.
Summary for 206966
Tradename:XEGLYZE
Applicant:Hatchtech
Ingredient:abametapir
Patents:5
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 206966
Generic Entry Date for 206966*:
Constraining patent/regulatory exclusivity:
Dosage:
LOTION;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Suppliers and Packaging for NDA: 206966
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
XEGLYZE abametapir LOTION;TOPICAL 206966 NDA Dr. Reddy's Laboratories Inc. 43598-921 43598-921-11 1 BOTTLE in 1 CARTON (43598-921-11) / 200 g in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:LOTION;TOPICALStrength0.74%
Approval Date:Jul 24, 2020TE:RLD:Yes
Regulatory Exclusivity Expiration:Jul 24, 2025
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:⤷  Sign UpPatent Expiration:Dec 17, 2034Product Flag?YSubstance Flag?Delist Request?
Patented Use:TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS 6 MONTHS OF AGE AND OLDER
Patent:⤷  Sign UpPatent Expiration:Oct 28, 2026Product Flag?YSubstance Flag?Delist Request?
Patented Use:TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS 6 MONTHS OF AGE AND OLDER

Expired US Patents for NDA 206966

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 ⤷  Sign Up ⤷  Sign Up
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 ⤷  Sign Up ⤷  Sign Up
Hatchtech XEGLYZE abametapir LOTION;TOPICAL 206966-001 Jul 24, 2020 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.